PAR2/mTOR

Jianguo Xu1, Xin Li1, Xiaoli Zeng1

  • 1Department of Gerontal Respiratory Medicine, The First Hospital of Lanzhou University, Lanzhou, 730000, China.

PubMed
概括

普尼卡拉 (PCG) 通过抑制蛋白酶激活受体2 (PAR2) /mTOR通路,有效地治疗烟草烟雾诱导的呼吸道上皮细胞衰老,提供一种自然的治疗方法.